Interview with Hervé Dussart , President, AstraZeneca Turkey
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
Address: Büyükdere Cad. Yapı Kredi Plaza, B Blok, K:2-4, 34330 Levent – Istanbul / Turkey
,Turkey
Tel: +90 212 317 2300
Web: http://www.astrazeneca.com.tr/
Since 1999 with the mission to produce ideas that add value for the life of people spend their lives working for better quality, and performs a lot of research, AstraZeneca, has been undertaking major projects in Turkey within the framework of social responsibility . AstraZeneca to gain awareness of first aid at a young age, ‘First Aid’ project TOÇEV throughout Turkey and in conjunction with the Ministry of National Education conducts. Investigating the effects of socioeconomic and environmental factors on human health and will continue for 10 years, ‘Prospective Urban and Rural Epidemiology’ ‘PURE’ gold sponsor of the research all over the world. Continued under the leadership of our country, METSEND’in approximately 3000 people were included in this project. not only the disease-causing diseases, and investigating the causes and environments that support the work of public awareness in order to eliminate these causes, AstraZeneca, ‘Fast Forward-fast-forward’ approach, using the maximum to produce beneficial drugs, the patient needs to provide the most appropriate solutions and business processes through the developing world to adapt the driving force attack is considered.
AstraZeneca, research, development, prescription drugs, production, marketing and presentation of these services in the field, one of the most important international companies. Volume of $ 33 billion health care and chest infection, cardiology, gastroentereloji, oncology, central nervous system and leading position in diabetes care products offered by area is one of the world’s leading pharmaceutical companies
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
The president of Turkey’s social security institution, the SGK, discusses the evolution of healthcare spending over the past three years, and the underpinning principles guiding their drug reimbursement policy decisions.…
In the global theater of business and politics, Turkey increasingly leverages its location as an ideal vantage point where actors can seamlessly move between all things West and East. An…
Within the Ministry’s wide scope of activities aimed at promoting Turkish various industries and trade, what special role does the pharmaceutical sector play within these aspirations? The world we live…
Focus Reports has been here a bit more than three months, and heard different opinions. Some said highlighted Turkey’s strategic advantages – population, age distribution, geography, political and economic stability…
Would you like to provide our international readers with a brief introduction into Novo Nordisk’s Turkish affiliate? As you may know, Novo Nordisk has a rich history of over 85…
You are managing partner of Egon Zehnder Turkey since 2007. Could you start by introducing the company to our readers and its scope of activities in Turkey? Egon Zehnder International…
Cegedim has become a very strong partner for pharmaceutical companies worldwide, including Turkey. Nevertheless, with respect to healthcare, there are probably as many systems as countries. How does Cegedim adapt…
Pharmaceutical Executive and Focus Reports are of course about the industry but also about the people making it happen. So before anything would you like to introduce yourself to our…
After a significant experience in consumer goods at Procter & Gamble, you have been managing director of Janssen Turkey for 11 years. Over this last decade, the Turkish pharma market…
In an environment where the line between generic and innovator companies is less and less relevant, due to the growing trend of innovators integrating generics products in their portfolio through…
Omega CRO was the first clinical trial company in Turkey. A few years later, in 2002, we saw a sharp increase of similar businesses, including Quintiles. What spurred the establishment…
After a significant experience in consumer goods at Procter & Gamble, you have been managing director of Janssen Turkey for 11 years. Over this last decade, the Turkish pharma market…
See our Cookie Privacy Policy Here